基于Mesh网的矿工心电信号无线监测系统研究

在矿难事故发生后实时监测被困矿工的生命体征,能够给营救工作提供重要的信息参考,因此设计了一款基于Mesh网的矿工心电信号无线监测系统.通过ADS1292心电检测模块对矿工的实时心电信息进行监测,然后将心电数据经过STM32F103单片机处理后通过OLED屏显示出来.同时,处理后的数据还可以通过无线组网模块发送至上位机进行显示,从而实现对井下采煤工人生命体征进行远程监测的目的.测试结果表明:该系统可以准确获取矿工心电信号波形,实测心率误差不超过4％,具有良好的应用前景和实用价值.     

基于熵评价模态分解的雷达信号双谱特征识别

针对在低信噪比下雷达信号调制识别准确率低、抗噪性差的问题, 提出一种基于熵评价模态分解和双谱特征提取的识别方法。利用双谱可以抑制高斯噪声的特点, 分析了在低信噪比下进行信号调制识别的可行性并引入了噪声项。由于噪声项的干扰, 双谱在0 dB以下时, 噪声抑制效果变差, 提出了基于信息熵评价的经验模态化分解对信号进行预处理, 提高信噪比。最后, 设计了卷积神经网络分类器, 实现对不同调制类型信号的识别。仿真实验结果表明, 本文方法相比传统方法具有良好的抗噪性, 能够在低信噪比下对不同类型信号进行有效识别。     

数字化转型背景下我国金融机构业务与技术融合发展的路径

近年来,我国金融行业数字化转型不断提速,金融机构数字化转型已迫在眉睫.金融机构面临的数字化转型环境包括3个方面:一是大数据走向跨界融合;二是人工智能加速发展;三是区块链等技术建立了新型连接关系.基于以上环境分析,文章认为金融机构数字化转型的核心在于业务与技术融合,需要在机制、组织、架构、人才和文化层面实行再造.     

科技创业孵化载体专业化发展问题与对策研究

进入新发展阶段后,科技创新创业活动对孵化服务提出了更高的要求,科技创业载体需要加快提升专业化、精准化服务能力.文章基于2016-2019年全国科技创业孵化载体发展数据,全面分析专业化科技创业孵化载体建设发展现状,剖析了科技创业孵化载体在专业化建设方面存在的方向不清、动力不足、能力不够、模式不明、机制不畅等问题,从建立评价指标体系、明确建设主体、提升服务能力、加强资源开放和政策供给等方面提出对策建议.     

2017—2019 年北京地区实验动物质量抽检结果分析

摘要:目的 比对分析 2017—2019 年北京地区实验动物微生物及遗传质量监测结果,为实验动物产业发展提供参考。 方法 按照国家和地方现行实验动物检测标准,对北京地区实验动物生产单位进行抽检,并发布检测报告。按照报告数据,对此阶段小鼠、大鼠、豚鼠、地鼠、兔、犬、猴和小型猪共 8 个品种的实验动物按照品种、等级、单位等进行分类,分析质量问题,并与 2014—2016 年同期实验动物质量比对,分析变化趋势。 结果 2017—2019 年分别抽检动物 144、131 和 135 批次,检出不合格批次分别为 30、15 和 17 批。 不合格主要因素为兔、犬及猪免疫不达标(20 批) ,病原感染 20 批,未发现遗传变异。 与 2014—2016 年同期相比,未检出遗传问题相同,免疫不达标状况好转,但病原感染出现上升。 结论 通过质量分析比对,能够为实验动物产业健康发展提供数据支持。     

一类离散时间复杂网络系统的输出同步

利用线性稳定性理论和Lyapunov函数方法,研究了一类离散时间复杂网络系统的输出同步问题,得到了系统输出指数同步的充分性条件,数值算例表明了方法的有效性.     

民族高校工商管理专业实践教学体系创新研究

围绕工商管理专业培养具有较强实践能力和高素质管理人才的目标,分析当前实践教学中的误区,通过构建全社会参与的工商管理专业人才实践教学社会网络,建立贯穿大学四年学习全周期的五大实践教学培养体系,对工商管理专业学生进行基础素养实践能力和专业素养实践能力培养,探索工商管理专业人才实践能力培养模式和体系。     

Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma

The NLRP3 inflammasome is a critical innate immune pathway responsible for producing active interleukin (IL)-1β, which is associated with tumor development and immunity. However, the mechanisms regulating the inflammatory microenvironment, tumorigenesis and tumor immunity are unclear. Herein, we show that the NLRP3 inflammasome was over-expressed in human HNSCC tissues and that the IL-1β concentration was increased in the peripheral blood of HNSCC patients. Additionally, elevated NLRP3 inflammasome levels were detected in tumor tissues of Tgfbr1/Pten 2cKO HNSCC mice, and elevated IL-1β levels were detected in the peripheral blood serum, spleen, draining lymph nodes and tumor tissues. Blocking NLRP3 inflammasome activation using MCC950 remarkably reduced IL-1β production in an HNSCC mouse model and reduced the numbers of myeloid-derived suppressor cells (MDSCs), regulatory T cells (Tregs) and tumor-associated macrophages (TAMs). Moreover, inhibiting NLRP3 inflammasome activation increased the numbers of CD4⁺ and CD8⁺ T cells in HNSCC mice. Notably, the numbers of exhausted PD-1⁺ and Tim3⁺ T cells were significantly reduced. A human HNSCC tissue microarray showed that NLRP3 inflammasome expression was correlated with the expression of CD8 and CD4, the Treg marker Foxp3, the MDSC markers CD11b and CD33, and the TAM markers CD68 and CD163, PD-1 and Tim3. Overall, our results demonstrate that the NLRP3 inflammasome/IL-1β pathway promotes tumorigenesis in HNSCC and inactivation of this pathway delays tumor growth, accompanied by decreased immunosuppressive cell accumulation and an increased number of effector T cells. Thus, inhibition of the tumor microenvironment through the NLRP3 inflammasome/IL-1β pathway may provide a novel approach for HNSCC therapy.     

Microsatellite instability in gastric cancer: molecular bases,clinical perspectives,and new treatment approaches

Gastric cancer is one of the most aggressive malignancies, with limited treatment options in both locally advanced and metastatic setting, resulting in poor prognosis. Based on genomic characterization, stomach tumour has recently been described as a heterogeneous disease composed by different subtypes, each of them with peculiar molecular aspects and specific clinical behaviour. With an incidence of 22% among all western gastric tumour cases, stomach cancer with microsatellite instability was identified as one of these subgroups. Retrospective studies and limited prospective trials reported differences between gastric cancers with microsatellite stability and those with instability, mainly concerning clinical and pathological features, but also in regard to immunological microenvironment, correlation with prognostic value, and responses to treatment. In particular, gastric cancer with microsatellite instability constitutes a small but relevant subgroup associated with older age, female sex, distal stomach location, and lower number of lymph-node metastases. Emerging data attribute to microsatellite instability status a favourable prognostic meaning, whereas the poor outcomes reported after perioperative chemotherapy administration suggest a detrimental role of cytotoxic drugs in this gastric cancer subgroup. The strong immunogenicity and the widespread expression of immune-checkpoint ligands make microsatellite instability subtype more vulnerable to immunotherapeutic approach, e.g., with anti-PD-L1 and anti-CTLA4 antibodies. Since gastric cancer with microsatellite instability shows specific features and clinical behaviour not overlapping with microsatellite stable disease, microsatellite instability test might be suitable for inclusion in a diagnostic setting for all tumour stages to guarantee the most targeted and effective treatment to every patient.